secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001193125-24-279656
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Jazz CEO Bruce Cozadd to retire by end of 2025; company to search for successor
-------------------------------------------------------------------------------

- Bruce Cozadd notified Board of intent to retire as CEO upon appointment of successor.
- Formal search process will consider both internal and external candidates for CEO.
- After retiring as CEO, Cozadd will continue to serve as Chairperson of the Board.
- Cozadd remains CEO until successor is appointed; transition expected by end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524279656/0001193125-24-279656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524279656/d907309d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-279656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer